Initiation of Antiresorptive Drug Treatment during Endocrine Therapy for Breast Cancer—A Retrospective Cohort Study of 161,492 Patients in Germany

Endocrine therapy (ET), which significantly reduces breast cancer (BC) recurrence and mortality rates, is the primary systemic therapy for hormone receptor positive BC. However, in addition to frequently reported TAM- and AI-related side effects, such as hot flashes, arthralgias, and myalgias, treat...

תיאור מלא

מידע ביבליוגרפי

Autoren:	Gremke, Niklas, Griewing, Sebastian, Kadys, Arturas, Kostev, Karel, Wagner, Uwe, Kalder, Matthias
פורמט:	Artikel
שפה:	אנגלית
יצא לאור:	Philipps-Universität Marburg 2023
נושאים:	endocrine therapy denosumab Medizin bisphosphonates Germany breast cancer tamoxifen antiresorptive therapy aromatase inhibitors Medical sciences Medicine
גישה מקוונת:	PDF-Volltext
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!